Organoids Market to Grow at a CAGR of 22.1% to reach US$ 3,420.40 Million from 2020 to 2027

    Organoids Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, Others); Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, Others); Source (Pluripotent Stem Cells, Organ-specific Adult Stem Cells), and Geography

    Publication Month: Jan 2021 | Report Code: TIPRE00017616 | No. of Pages: 174 | Category: Biotechnology | Status: Published

    The organoids market was valued at US$ 689.47 million in 2019 and it is projected to reach US$ 3,420.40 million by 2027; it is expected to grow at a CAGR of 22.1% from 2020 to 2027.

    Organoids are tiny, self-organized three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ, or to express selected aspects of it like producing only certain types of cells. Organoids grow from stem cells—cells that can divide indefinitely and produce different types of cells as part of their progeny. Organoids can range in size from less than the width of a hair to five millimeters.

    The scope of the organoids market includes type, application, source, and region. The organoids market is analyzed based on regions, such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the organoids market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.

    Lucrative Regions for Organoids Market

    Market Insights

    Organoids are microscopic and self-organizing 3D structures, which are grown from stem cells in vitro. They review various structural and functional characteristics of their in vivo counterpart organs. This multipurpose technology has led to the development of several novel human cancer models. It is now possible to create indefinitely expanding organoids starting from the tumor tissue of individuals suffering from a range of carcinomas. Alternatively, CRISPR-based gene modification allows the engineering of organoid models of cancer by introducing any combination of cancer gene alterations to normal organoids. Tumor organoids, when combined with immune cells and fibroblasts, becomes a model for the cancer microenvironment enabling immune-oncology applications. Also, recent studies have proved that organoids have a place in personalized medicine approaches.

    The constant progress in organoid technology has paved the way for tumors and patient-centric 3D cultures of cells isolated from tumor biopsies. Over the past few decades, organoids have been generated from diverse human cancers, related to breast, colon, pancreas, prostate, bladder, and liver. Studies involving these models are increasing knowledge of the etiology and features of these malignancies. Due to constant advancements, in the current scenario, tumoroid lines are increasingly being passed in vitro, which opens up new paths for a range of downstream applications. Moreover, 3D-based cultures offer added advantages over the conventional 2D cancer-derived cell lines. Further, research and development activities have specified that tumoroid culturing is highly effectual in allowing the collection of various cancer subtypes from a large pool of patients. As organoids can be easily derived and expanded from single cancer cells, the adoption of organoids to mimic intratumor diversification in culture is increasing, which, in turn is projected to propel the global organoids market during the forecast period.

    Increasing Adoption of Personalized Drugs

    Personalized medicine is a growing area of treatment that relies on specific drug delivery and dosing. As per a study published by Personalized Medicine Coalition (PMC), in 2005, personalized medicines accounted for only 5% of the new FDA approved molecular entities; whereas, they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, which is likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years.

    The implementation of organoids to create personalized drug therapies is providing some exciting opportunities for improving patient care. Recent research has highlighted that more than 50% of consumers express an interest in purchasing customized products or services. This demand would require adaptation by multiple industries, including the pharmaceutical sector. Since the Precision Medicine’s Initiative was released in the US in 2015, pharmaceutical research has been pursuing the development of more tailored treatments in an attempt to make medicines safer and effective.

    Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor’s genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical settings. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene–drug association treatment, identification of new therapies, and prediction of patient outcome.
    Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors may result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

    Type Insights

    Based on type, the global organoids market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. In 2019, the intestine segment held the largest market share. This segment is also expected to dominate the market in 2027 as various experimental techniques have also been developed in parallel with, and applied to, intestinal organoid cultures with a scientifically synergistic effect. Moreover, the kidney segment is anticipated to grow at the fastest rate during the forecast period.

    Application Insights

    Based on application, the global organoids market is segmented into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. In 2019, the developmental biology segment held the largest market share in the organoids market. This segment is also expected to dominate the market by 2027, as it is considered a primary investigative research tool of the human developmental biology. Moreover, organoids derived from embryonic stem cells offer complete understanding of the embryonic process development and insights on development of the stem cells.

    Source Insights

    In terms of source, the global organoids market is segmented into pluripotent stem cells and organ-specific adult stem cells. In 2019, the pluripotent stem cells segment held the largest market share. This segment is also expected to dominate the market during the forecast period as induced pluripotent stem cells are considered an important resource for regenerative medicine to replace diseased or damaged tissues. Moreover, induced pluripotent stem cells have numerous biomedical applications in basic research, drug screening, toxicological studies, disease modeling, and cell therapy.

    Global Organoids Market, by Source – 2019 & 2027

    Strategic Insights

    Product launch and mergers & acquisitions are highly adopted strategies in the global organoids market. A few recent key product developments are listed below:

    January 2020: Merck and BioMed X collaborated for a new research program in autoimmune diseases. This research would involve use of conventional and high-throughput metagenomics and generation of intestinal organoids from murine and human subjects for identification of biomarkers of autoimmune diseases.

    November 2018: Cellesce Ltd. entered into partnership with Manchester BIOGEL for development of fully synthetic animal free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable manufacture, scale up, and improved reproducibility of patient-derived organoids.

    The coronavirus pandemic is estimated to have a significant impact on the organoids market. Majority of the pharmaceutical companies around the globe are engaged in the development of vaccines for coronavirus. Moreover, COVID-19 has also caused increased interest in human lung organoid models. However, this shift of focus is anticipated to have a positive impact on the other segments of the market. Disruptions in supply chain caused due to halt in global operations are projected to have an adverse impact on the market.

    Organoids – Market Segmentation

    By Type

    • Stomach
    • Intestine
    • Liver
    • Pancreas
    • Lung
    • Brain
    • Kidney
    • Others

    By Application

    • Developmental Biology
    • Disease Pathology of Infectious Disease
    • Regenerative Medicine
    • Drug Toxicity and Efficacy Testing
    • Drug Discovery and Personalized Medicine
    • Others

    By Source

    • Pluripotent Stem Cells
    • Organ-Specific Adult Stem Cells

    By Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Middle East & Africa (MEA)
      • Saudi Arabia
      • South Africa
      • UAE
      • Rest of Middle East & Africa
    • South America (SCAM)
      • Brazil
      • Argentina
      • Rest of South & Central America

    Company Profiles

    • STEMCELL Technologies, Inc.
    • Cellesce Ltd.
    • Hubrecht Organoid Technology
    • Definigen
    • 3Dnamics, Inc.
    • Organoid Therapeutics
    • PeproTech, Inc.
    • Thermo Fisher Scientific
    • Corning Incorporated (Life Sciences)
    • Merck KGgA

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Organoids Market– By Type

    1.3.2 Global Organoids Market– By Application

    1.3.3 Global Organoids Market– By Source

    1.3.4 Global Organoids Market– By Geography

    2. Organoids Market– Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Global Organoids Market– Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America PEST Analysis

    4.2.2 Europe PEST Analysis

    4.2.3 APAC PEST Analysis

    4.2.4 SCAM PEST Analysis

    4.2.5 MEA PEST Analysis

    4.3 Expert Opinion

    5. Organoids Market– Industry Dynamics

    5.1 Market Drivers

    5.1.1 Increasing Demand for Tumor Modelling and Biobanking

    5.1.2 Increasing Adoption of Personalized Drugs

    5.1.3 Growing Focus on Developing Alternatives for Animal Testing Models

    5.2 Market Restraints

    5.2.1 Issues Related to the Incorporation of Organoids into Existing Workflows

    5.2.2 Dearth of Skilled Professionals

    5.3 Market Opportunities

    5.3.1 Increasing Focus on Drug Discovery Activities

    5.4 Future Trends

    5.4.1 Combining Organoid with Organ-On-A-Chip

    5.5 Impact Analysis

    6. Organoids Market– Global Analysis

    6.1 Global Organoids Market Revenue Forecast and Analysis

    6.2 Global Organoids Market, By Geography - Forecast and Analysis

    6.3 Market Positioning of Key Players

    7. Organoids Market Analysis – By Type

    7.1 Overview

    7.2 Organoids Market Revenue Share, by Type (2019 and 2027)

    7.3 Stomach

    7.3.1 Overview

    7.3.2 Stomach: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    7.4 Intestine

    7.4.1 Overview

    7.4.2 Intestine: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    7.5 Liver

    7.5.1 Overview

    7.5.2 Liver: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    7.6 Pancreas

    7.6.1 Overview

    7.6.2 Pancreas: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    7.7 Lung

    7.7.1 Overview

    7.7.2 Lung: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    7.8 Brain

    7.8.1 Overview

    7.8.2 Brain: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    7.9 Kidney

    7.9.1 Overview

    7.9.2 Kidney: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    7.10 Others

    7.10.1 Overview

    7.10.2 Others: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    8. Organoids Market Analysis – By Application

    8.1 Overview

    8.2 Organoids Market Share, by Application, 2019 and 2027, (%)

    8.3 Developmental Biology

    8.3.1 Overview

    8.3.2 Developmental Biology: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    8.4 Disease Pathology of Infectious Disease

    8.4.1 Overview

    8.4.2 Disease Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    8.5 Regenerative Medicine

    8.5.1 Overview

    8.5.2 Regenerative Medicine: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    8.6 Drug Toxicity and Efficacy Testing

    8.6.1 Overview

    8.6.2 Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    8.7 Drug Discovery and Personalized Medicine

    8.7.1 Overview

    8.7.2 Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    8.8 Others

    8.8.1 Overview

    8.8.2 Others: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    9. Organoids Market Analysis – By Source

    9.1 Overview

    9.2 Organoids Market Share, by Source, 2019 and 2027, (%)

    9.3 Pluripotent Stem Cells

    9.3.1 Overview

    9.3.2 Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    9.4 Organ-Specific Adult Stem Cells

    9.4.1 Overview

    9.4.2 Organ-Specific Adult Stem Cells: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    10. Organoids Market – Geographic Analysis

    10.1 North America: Organoids Market

    10.1.1 Overview

    10.1.2 North America: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.3 North America: Organoids Market, by Type, 2018–2027 (USD Million)

    10.1.4 North America: Organoids Market, by Application, 2018–2027 (USD Million)

    10.1.5 North America: Organoids Market, by Source, 2018–2027 (USD Million)

    10.1.6 North America: Organoids Market, by Country, 2019 & 2027 (%)

    10.1.7 US: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.7.1 US: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.7.2 US: Organoids Market, by Type, 2018–2027 (USD Million)

    10.1.7.3 US: Organoids Market, by Application, 2018–2027 (USD Million)

    10.1.7.4 US: Organoids Market, by Source, 2018–2027 (USD Million)

    10.1.8 Canada: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.8.1 Canada: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.8.2 Canada: Organoids Market, by Type, 2018–2027 (USD Million)

    10.1.8.3 Canada: Organoids Market, by Application, 2018–2027 (USD Million)

    10.1.8.4 Canada: Organoids Market, by Source, 2018–2027 (USD million)

    10.1.9 Mexico: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.9.1 Mexico: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.9.2 Mexico: Organoids Market, by Type, 2018–2027 (USD Million)

    10.1.9.3 Mexico: Organoids Market, by Application, 2018–2027 (USD Million)

    10.1.9.4 Mexico: Organoids Market, by Source, 2018–2027 (USD million)

    10.2 Europe: Organoids Market

    10.2.1 Overview

    10.2.2 Europe: Organoids Market - Revenue and Forecast to 2027 (USD Million)

    10.2.3 Europe: Organoids Market, by Type, 2018–2027 (USD Million)

    10.2.4 Europe: Organoids Market, by Application, 2018–2027 (USD Million)

    10.2.5 Europe: Organoids Market, by Source, 2018–2027 (USD Million)

    10.2.6 Europe: Organoids Market, by Country, 2019 & 2027 (%)

    10.2.7 Germany: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.7.1 Germany: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.7.2 Germany: Organoids Market, by Type, 2018–2027 (USD Million)

    10.2.7.3 Germany: Organoids Market, by Application, 2018–2027 (USD Million)

    10.2.7.4 Germany: Organoids Market, by Source, 2018–2027 (USD million)

    10.2.8 UK: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.8.1 UK Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.8.2 UK: Organoids Market, by Type, 2018–2027 (USD Million)

    10.2.8.3 UK: Organoids Market, by Application, 2018–2027 (USD Million)

    10.2.8.4 UK: Organoids Market, by Source, 2018–2027 (USD million)

    10.2.9 France: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.9.1 France: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.9.2 France: Organoids Market, by Type, 2018–2027 (USD Million)

    10.2.9.3 France: Organoids Market, by Application, 2018–2027 (USD Million)

    10.2.9.4 France: Organoids Market, by Source, 2018–2027 (USD million)

    10.2.10 Spain: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.10.1 Spain: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.10.2 Spain: Organoids Market, by Type, 2018–2027 (USD Million)

    10.2.10.3 Spain: Organoids Market, by Application, 2018–2027 (USD Million)

    10.2.10.4 Spain: Organoids Market, by Source, 2018–2027 (USD million)

    10.2.11 Italy: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.11.1 Italy: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.11.2 Italy: Organoids Market, by Type, 2018–2027 (USD Million)

    10.2.11.3 Italy: Organoids Market, by Application, 2018–2027 (USD Million)

    10.2.11.4 Italy: Organoids Market, by Source, 2018–2027 (USD million)

    10.2.12 Rest of Europe: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.12.1 Rest of Europe: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.2.12.2 Rest of Europe: Organoids Market, by Type, 2018–2027 (USD Million)

    10.2.12.3 Rest of Europe: Organoids Market, by Application, 2018–2027 (USD Million)

    10.2.12.4 Rest of Europe: Organoids Market, by Source, 2018–2027 (USD million)

    10.3 Asia Pacific: Organoids Market

    10.3.1 Overview

    10.3.2 Asia Pacific: Organoids Market - Revenue and Forecast to 2027 (USD Million)

    10.3.3 Asia Pacific: Organoids Market, by Type, 2018–2027 (USD Million)

    10.3.4 Asia Pacific: Organoids Market, by Application, 2018–2027 (USD Million)

    10.3.5 Asia Pacific: Organoids Market, by Source, 2018–2027 (USD Million)

    10.3.6 Asia Pacific: Organoids Market, by Country, 2019 & 2027 (%)

    10.3.7 China: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.7.1 China: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.7.2 China: Organoids Market, by Type, 2018–2027 (USD Million)

    10.3.7.3 China: Organoids Market, by Application, 2018–2027 (USD Million)

    10.3.7.4 China: Organoids Market, by Source, 2018–2027 (USD million)

    10.3.8 Japan: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.8.1 Japan: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.8.2 Japan: Organoids Market, by Type, 2018–2027 (USD Million)

    10.3.8.3 Japan: Organoids Market, by Application, 2018–2027 (USD Million)

    10.3.8.4 Japan: Organoids Market, by Source, 2018–2027 (USD million)

    10.3.9 India: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.9.1 India: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.9.2 India: Organoids Market, by Type, 2018–2027 (USD Million)

    10.3.9.3 India: Organoids Market, by Application, 2018–2027 (USD Million)

    10.3.9.4 India: Organoids Market, by Source, 2018–2027 (USD million)

    10.3.10 South Korea: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.10.1 South Korea: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.10.2 South Korea: Organoids Market, by Type, 2018–2027 (USD Million)

    10.3.10.3 South Korea: Organoids Market, by Application, 2018–2027 (USD Million)

    10.3.10.4 South Korea: Organoids Market, by Source, 2018–2027 (USD million)

    10.3.10.5 Australia: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.10.6 Australia: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.10.7 Australia: Organoids Market, by Type, 2018–2027 (USD Million)

    10.3.10.8 Australia: Organoids Market, by Application, 2018–2027 (USD Million)

    10.3.10.9 Australia: Organoids Market, by Source, 2018–2027 (USD million)

    10.3.11 Rest of Asia Pacific: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.11.1 Rest of Asia Pacific: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.3.11.2 Rest of Asia Pacific: Organoids Market, by Type, 2018–2027 (USD Million)

    10.3.11.3 Rest of Asia Pacific: Organoids Market, by Application, 2018–2027 (USD Million)

    10.3.11.4 Rest of Asia Pacific: Organoids Market, by Source, 2018–2027 (USD million)

    10.4 South and Central America: Organoids Market

    10.4.1 Overview

    10.4.2 South and Central America: Organoids Market, by Country, 2019 & 2027 (%)

    10.4.3 South and Central America: Organoids Market, by Type, 2018–2027 (USD Million)

    10.4.4 South and Central America: Organoids Market, by Application, 2018–2027 (USD Million)

    10.4.5 South and Central America: Organoids Market, by Source, 2018–2027 (USD Million)

    10.4.6 South and Central America: Organoids Market, by Country, 2019 & 2027 (%)

    10.4.7 Brazil: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.4.7.1 Brazil: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.4.8 Brazil: Organoids Market, by Type, 2018–2027 (USD Million)

    10.4.9 Brazil: Organoids Market, by Application, 2018–2027 (USD Million)

    10.4.10 Brazil: Organoids Market, by Source, 2018–2027 (USD Million)

    10.4.11 Argentina: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.4.11.1 Argentina: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.4.12 Argentina: Organoids Market, by Type, 2018–2027 (USD Million)

    10.4.13 Argentina: Organoids Market, by Application, 2018–2027 (USD Million)

    10.4.14 Argentina: Organoids Market, by Source, 2018–2027 (USD Million)

    10.4.15 Rest of Central and South America: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.4.15.1 Rest of Central and South America: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.4.16 Rest of Central and South America: Organoids Market, by Type, 2018–2027 (USD Million)

    10.4.17 Rest of Central and South America: Organoids Market, by Application, 2018–2027 (USD Million)

    10.4.18 Rest of Central and South America: Organoids Market, by Source, 2018–2027 (USD Million)

    10.1 Middle East & Africa: Organoids Market

    10.1.1 Overview

    10.1.2 Middle East & Africa: Organoids Market - Revenue and Forecast to 2027 (USD Million)

    10.1.3 Middle East & Africa Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    10.1.4 Middle East & Africa Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.1.5 Middle East & Africa Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    10.1.6 Middle East & Africa: Organoids Market Share by Country – 2019 & 2027, (%)

    10.1.7 Saudi Arabia: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.7.1 Saudi Arabia: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.7.2 Saudi Arabia Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    10.1.7.3 Saudi Arabia Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.1.7.4 Saudi Arabia Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    10.1.8 UAE: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.8.1 UAE: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.8.2 UAE Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    10.1.8.3 UAE Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.1.8.4 UAE Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    10.1.9 South Africa: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    10.1.9.1 South Africa: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.9.2 South Africa Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    10.1.9.3 South Africa Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.1.9.4 South Africa Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    10.1.10 Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    10.1.10.1 Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    10.1.10.2 Rest of Middle East and Africa Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    10.1.10.3 Rest of Middle East and Africa Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10.1.10.4 Rest of Middle East and Africa Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    11. Impact Of COVID-19 Pandemic on Global Organoids Market

    11.1 North America: Impact Assessment of COVID-19 Pandemic

    11.2 Europe: Impact Assessment of COVID-19 Pandemic

    11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

    12. Industry Landscape

    12.1 Overview

    12.2 Growth Strategies Done by the Companies in the Market, (%)

    12.4 Organic Developments

    12.4.1 Overview

    12.5 Inorganic Developments

    12.5.1 Overview

    13. Company Profiles

    13.1 STEMCELL Technologies Inc.

    13.1.1 Key Facts

    13.1.2 Business Description

    13.1.3 Products and Services

    13.1.4 Financial Overview

    13.1.5 SWOT Analysis

    13.1.6 Key Developments

    13.2 Cellesce Ltd

    13.2.1 Key Facts

    13.2.2 Business Description

    13.2.3 Products and Services

    13.2.4 Financial Overview

    13.2.5 SWOT Analysis

    13.2.6 Key Developments

    13.3 Hubrecht Organoid Technology

    13.3.1 Key Facts

    13.3.2 Business Description

    13.3.3 Products and Services

    13.3.4 Financial Overview

    13.3.5 SWOT Analysis

    13.3.6 Key Developments

    13.4 Definigen

    13.4.1 Key Facts

    13.4.2 Business Description

    13.4.3 Products and Services

    13.4.4 Financial Overview

    13.4.5 SWOT Analysis

    13.4.6 Key Developments

    13.5 3Dnamics Inc.

    13.5.1 Key Facts

    13.5.2 Business Description

    13.5.3 Products and Services

    13.5.4 Financial Overview

    13.5.5 SWOT Analysis

    13.5.6 Key Developments

    13.6 Organoid Therapeutics

    13.6.1 Key Facts

    13.6.2 Business Description

    13.6.3 Products and Services

    13.6.4 Financial Overview

    13.6.5 SWOT Analysis

    13.6.6 Key Developments

    13.7 PeproTech, Inc

    13.7.1 Key Facts

    13.7.2 Business Description

    13.7.3 Products and Services

    13.7.4 Financial Overview

    13.7.5 SWOT Analysis

    13.7.6 Key Developments

    13.8 THERMO FISHER SCIENTIFIC INC.

    13.8.1 Key Facts

    13.8.2 Business Description

    13.8.3 Products and Services

    13.8.4 Financial Overview

    13.8.5 SWOT Analysis

    13.8.6 Key Developments

    13.9 Corning Incorporated

    13.9.1 Key Facts

    13.9.2 Business Description

    13.9.3 Products and Services

    13.9.4 Financial Overview

    13.9.5 SWOT Analysis

    13.9.6 Key Developments

    13.10 MERCK KGaA

    13.10.1 Key Facts

    13.10.2 Business Description

    13.10.3 Products and Services

    13.10.4 Financial Overview

    13.10.5 SWOT Analysis

    13.10.6 Key Developments

    14. Appendix

    14.1 About the Insight Partners

    14.2 Glossary of Terms


    LIST OF TABLES

    Table 1. North America Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 2. North America Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 3. North America Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 4. US Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 5. US Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 6. US Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 7. Canada Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 8. Canada Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 9. Canada Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 10. Mexico Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 11. Mexico Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 12. Mexico Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 13. Europe Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 14. Europe Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 15. Europe Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 16. Germany Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 17. Germany Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 18. Germany Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 19. UK Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 20. UK Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 21. UK Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 22. France Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 23. France Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 24. France Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 25. Spain Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 26. Spain Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 27. Spain Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 28. Italy Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 29. Italy Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 30. Italy Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 31. Rest of Europe Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 32. Rest of Europe Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 33. Rest of Europe Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 34. Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 35. Asia Pacific Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 36. Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 37. China Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 38. China Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 39. China Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 40. Japan Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 41. Japan Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 42. Japan Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 43. India Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 44. India Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 45. India Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 46. South Korea Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 47. South Korea Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 48. South Korea Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 49. Australia Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 50. Australia Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 51. Australia Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 52. Rest of Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 53. Rest of Asia Pacific Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 54. Rest of Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 55. South and Central America Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 56. South and Central America Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 57. South and Central America Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 58. Brazil Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 59. Brazil Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 60. Brazil Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 61. Argentina Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 62. Argentina Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 63. Argentina Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 64. Rest of Central and South America Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 65. Rest of Central and South America Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 66. Rest of Central and South America Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 67. Middle East & Africa Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 68. Middle East & Africa Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 69. Middle East & Africa Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 70. Saudi Arabia Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 71. Saudi Arabia Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 72. Saudi Arabia Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 73. UAE Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 74. UAE Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 75. UAE Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 76. South Africa Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 77. South Africa Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 78. South Africa Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 79. Rest of Middle East and Africa Organoids Market, by Type – Revenue and Forecast to 2027 (USD Million)

    Table 80. Rest of Middle East and Africa Organoids Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 81. Rest of Middle East and Africa Organoids Market, by Source – Revenue and Forecast to 2027 (USD Million)

    Table 82. Organic Developments Done By Companies

    Table 83. Inorganic Developments Done By Companies

    Table 84. Glossary of Terms, Organoids Market


    LIST OF FIGURES

    Figure 1. Organoids Market Segmentation

    Figure 2. Organoids Segmentation, By Region

    Figure 3. Global Organoids Market Overview

    Figure 4. Intestine Organoids Segment Held Largest Share of Organoids Market

    Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period

    Figure 6. Organoids Market, by Geography (US$ Million)

    Figure 7. Global Organoids Market– Leading Country Markets (US$ Million)

    Figure 8. Global Organoids Market, Industry Landscape

    Figure 9. North America: PEST Analysis

    Figure 10. Europe: PEST Analysis

    Figure 11. APAC: PEST Analysis

    Figure 12. SCAM: PEST Analysis

    Figure 13. MEA: PEST Analysis

    Figure 14. Organoids Market Impact Analysis of Driver and Restraints

    Figure 15. Global Organoids Market– Revenue Forecast and Analysis – 2019- 2027

    Figure 16. Global Organoids Market– By Geography Forecast and Analysis – 2019- 2027

    Figure 17. Market Positioning of Key Players In Global Organoids Market

    Figure 18. Organoids Market Revenue Share, by Type (2019 and 2027)

    Figure 19. Stomach: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 20. Intestine: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 21. Liver: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 22. Pancreas Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 23. Lung: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 24. Brain: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 25. Kidney: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 26. Others: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 27. Organoids Market Share, by Application, 2019 and 2027 (%)

    Figure 28. Developmental Biology: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 29. Disease Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 30. Regenerative Medicine: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 31. Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 32. Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 33. Others: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 34. Organoids Market Share, by Source, 2019 and 2027 (%)

    Figure 35. Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 36. Organ-Specific Adult Stem Cells: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 37. North America: Organoids Market, by Key Country – Revenue (2019) (USD Million)

    Figure 38. North America Organoids Market Revenue and Forecast to 2027 (USD Million)

    Figure 39. North America: Organoids Market, by Country, 2019 & 2027 (%)

    Figure 40. US: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 41. Canada: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 42. Mexico: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 43. Europe: Organoids Market, by Key Country – Revenue (2019) (USD Million)

    Figure 44. Europe Organoids Market Revenue and Forecast to 2027 (USD Million)

    Figure 45. Europe: Organoids Market, by Country, 2019 & 2027 (%)

    Figure 46. Germany: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 47. UK: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 48. France: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 49. Spain: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 50. Italy: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 51. Rest of Europe: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 52. Asia Pacific: Organoids Market, by Key Country – Revenue (2019) (USD Million)

    Figure 53. Asia Pacific Organoids Market Revenue and Forecast to 2027 (USD Million)

    Figure 54. China: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 55. Japan: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 56. India: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 57. South Korea: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 58. Australia: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 59. Rest of Asia Pacific: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 60. South and Central America: Organoids Market, by Key Country – Revenue (2019) (USD Million)

    Figure 61. South and Central America: Organoids Market, by Country, 2019 & 2027 (%)

    Figure 62. South and Central America: Organoids Market, by Country, 2019 & 2027 (%)

    Figure 63. Brazil: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 64. Argentina: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 65. Rest of Central and South America: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 66. Middle East & Africa: Organoids Market, by Key Country – Revenue (2019) (USD Million)

    Figure 67. Middle East & Africa Organoids Market Revenue and Forecast to 2027 (USD Million)

    Figure 68. Middle East & Africa: Organoids Market Share by Country – 2019 & 2027, (%)

    Figure 69. Saudi Arabia: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 70. UAE: Organoids Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 71. South Africa: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 72. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2027 (USD Million)

    Figure 73. Impact of COVID-19 Pandemic In North American Country Markets

    Figure 74. Impact of COVID-19 Pandemic In European Country Markets

    Figure 75. Impact of COVID-19 Pandemic In Asia Pacific Country Markets

    Figure 76. Impact Of COVID-19 Pandemic In Rest of the World Market

    Figure 77. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies - Organoids Market

    1. STEMCELL Technologies, Inc.
    2. Cellesce Ltd.
    3. Hubrecht Organoid Technology
    4. Definigen
    5. 3Dnamics, Inc.
    6. Organoid Therapeutics
    7. PeproTech, Inc.
    8. Thermo Fisher Scientific
    9. Corning Incorporated (Life Sciences)
    10. Merck KGgA
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the transient protein expression market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global transient protein expression market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
    TIPRE00017616
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Pricing
    • $3000
    • $4550
    • $6550
    • $8550

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst